The CD1d-Vδ2 hu-bsTCE-induced activation of type 1 NKT and/or Vγ9Vδ2-T cells resulted in significant lysis of patient-derived MM, AML, and CLL cells (Figures 5C–5E). Here, CD1D is linked to B-cell chronic lymphocytic leukemia.